$MSON (Misonix, Inc.)

$MSON {{ '2016-08-30T12:14:54+0000' | timeago}} • Announcement

Surgical device maker $MSON said, effective Sept. 2, Michael McManus, Jr. will resign as Director and Chairman of BoD and also as President and CEO, and Stavros Vizirgianakis, a member of BoD, will serve as Interim CEO on an unpaid basis. Company is in negotiations with Vizirgianakis to make him accept employment as full-time CEO.

$MDT {{ '2017-11-22T20:29:59+0000' | timeago}} • Webcast

In Oct., Animas announced to cease the manufacture and sale of its insulin pumps and partnered with $MDT to offer its customers the opportunity to transfer to a new device.With $JNJ exiting the insulin pump market in the US and Canada, $MDT now has access to the 90,000 patients who use Animas insulin pumps.

$MDT {{ '2017-11-22T20:27:57+0000' | timeago}} • Webcast

$MDT got US FDA approval for its MiniMed 670G hybrid closed-loop system and rolled the device out in a Priority Access program. It began shipping systems to patients in June. The company now expects growth to significantly improve in 3Q18 as it has finished shipping pumps for the program.

$ALG {{ '2017-11-22T18:04:23+0000' | timeago}} • Announcement

$ALG announced the retirement of Gary L. Martin from the BoD, effective Nov. 30, 2017. Martin had the joined the Board in 2007 and also served as Chairman since Jan. 5, 3016.

$TMO {{ '2017-11-22T16:06:12+0000' | timeago}} • Announcement

$TMO has received an unsolicited offer from TRC Capital to purchase up to one million shares of the company’s common stock for $181.75 per share in cash. According to Thermo Fisher, the offer price is about 4.43% lower than the closing price of its stock on November 17, 2017. The offer accounts for about 0.249% of the company’s outstanding shares.

$DLPH {{ '2017-11-22T16:01:37+0000' | timeago}} • Announcement

$DLPH has closed its acquisition of nuTonomy, a developer of autonomous driving (AD) software solutions. Terms of the transaction are consistent with those announced on October 24, 2017.

$MDT {{ '2017-11-21T17:06:41+0000' | timeago}} • Announcement

Given the recent events of hurricanes and wildfires, $MDT managed to restrict its revenue decline to just 4% for 2Q18. The medical-device maker saw its profit grow 81% on a GAAP basis. On adjusted basis, earnings fell 4% to $1.07 per share.

$A {{ '2017-11-21T15:04:12+0000' | timeago}} • Webcast

For FY18, $A expects pharma to moderate down slightly from a 6% growth rate delivered in FY17. Agilent expects China to maintain a high-single-digit growth rate. For Europe and the chemical and energy markets, while Agilent experienced unexpectedly strong FY17 growth, the company cautiously guided to lower growth in FY18.

$MDT {{ '2017-11-21T12:59:44+0000' | timeago}} • Infographic

$MDT Medtronic plc Earnings AlphaGraphic: Q2 2018 Highlights

$A {{ '2017-11-20T21:43:30+0000' | timeago}} • Announcement

$A expects 1Q18 revenue of $1.145-1.165Bil. First-quarter non-GAAP earnings are expected to be in the range of $0.55 to $0.57 per share. For FY18, Agilent expects revenue of $4.72-4.74Bil and non-GAAP earnings of $2.50-2.56 per share.

$A {{ '2017-11-20T21:40:09+0000' | timeago}} • Announcement

With net revenue soaring 7% to $1.19Bil in 4Q17, $A posted a 40% jump in net income of $177MM or $0.54 per diluted share.

$CNC {{ '2017-11-17T14:00:28+0000' | timeago}} • Announcement

$CNC appointed Mark Brooks as EVP and Chief Information Officer. Kevin Counihan has been appointed SVP of Products. Michael Neidorff will remain Chairman and CEO. Cynthia Brinkley, Jesse Hunter and Mark Brooks will continue to report to Michael Neidorff. Kevin Counihan will report to Brinkley.

$CNC {{ '2017-11-17T13:57:59+0000' | timeago}} • Announcement

$CNC appointed Cynthia Brinkley, currently EVP of Global Corporate Development, as President and COO. Jesse Hunter, EVP of Products, has been appointed EVP of Mergers & Acquisitions and Chief Strategy Officer. Michael Neidorff will remain Chairman and CEO.

$DLPH {{ '2017-11-15T15:04:32+0000' | timeago}} • Announcement

$DLPH, which will become two new stand-alone companies $APTV and Delphi Technologies, said Frank Dellaquila and Colin Parris have been named to the $APTV's BoD, effective with the final date of the spin-off.

$LH {{ '2017-11-15T14:38:42+0000' | timeago}} • Announcement

$LH announced the U.S. availability of the PD-L1 IHC 28-8 pharmDx assay as a complementary diagnostic for two newly approved indications. This is in connection with the use of $BMY's Opdivo (nivolumab) to treat patients with metastatic urothelial carcinoma, also referred to as bladder cancer, and squamous cell carcinoma of the head and neck.

$TMO {{ '2017-11-10T12:00:35+0000' | timeago}} • Announcement

$TMO has declared a quarterly cash dividend of $0.15 per share on its common stock. The dividend will be paid on January 15, 2018, to shareholders of record as of December 15, 2017.

$MDT {{ '2017-11-09T13:05:42+0000' | timeago}} • Announcement

Preliminary 2Q18 Results: $MDT worldwide revenue declined 4% to approx. $7.05Bil, with the decline driven by the company's divestiture of its Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency businesses to $CAH. The company expects the impact of Hurricane Maria to be approx. $0.03 to non-GAAP EPS for 2Q18.

$HUM {{ '2017-11-08T15:40:47+0000' | timeago}} • Webcast

For 2018, $HUM estimates membership growth to be in low-single digits. Next year, financial performance is expected to face headwinds from a non-deductible fee of about $1Bil and lower PDP growth in the pharmacy business.The transition associated with workforce reduction will be completed by January 2018, and its effects will show up in 1Q18.

$HUM {{ '2017-11-08T15:12:26+0000' | timeago}} • Webcast

$HUM continues to see lower-than-expected mail order pharmacy utilization in the coming quarters, particularly for new members in the Humana‐Walmart PDP offering. Humana has adopted various measures to reduce administrative costs in a sustainable way for 2018 and beyond. The workforce reduction strategy is expected to affect about 6% employees.

$HUM {{ '2017-11-08T14:43:15+0000' | timeago}} • Webcast

$HUM said it is planning investments in care coordination technology and analytics, to fill shortcomings in those areas. The expansion strategy will be executed using models such as Owned Primary Care Clinics and Alliance Clinics. The company is also looking for M&A opportunities in the ‘provider’ space, mainly for expansion of its MSL platform.

$HUM {{ '2017-11-08T14:10:47+0000' | timeago}} • Infographic

$HUM Humana, Inc. Earnings AlphaGraphic: Q3 2017 Highlights

Recent Transcripts

MDT (Medtronic plc)
Tuesday, November 21 2017 - 1:00pm
A (Agilent Technologies Inc.)
Monday, November 20 2017 - 9:30pm
HUM (Humana Inc.)
Wednesday, November 8 2017 - 2:00pm
MSON (Misonix, Inc.)
Tuesday, November 7 2017 - 9:30pm
MOH (Molina Healthcare, Inc.)
Thursday, November 2 2017 - 9:00pm
INTT (inTEST Corp.)
Thursday, November 2 2017 - 9:00pm
DLPH (Delphi Automotive PLC)
Thursday, November 2 2017 - 12:30pm
CI (Cigna Corp.)
Thursday, November 2 2017 - 12:30pm
ALG (Alamo Group, Inc.)
Wednesday, November 1 2017 - 3:00pm
OMI (Owens & Minor Inc.)
Wednesday, November 1 2017 - 12:00pm
ZBH (Zimmer Biomet Holdings, Inc.)
Wednesday, November 1 2017 - 12:00pm
LBY (Libbey Inc.)
Tuesday, October 31 2017 - 3:00pm
WCG (WellCare Health Plans, Inc.)
Tuesday, October 31 2017 - 1:30pm
SYK (Stryker Corporation)
Thursday, October 26 2017 - 8:30pm
IART (Integra LifeSciences Holdings Corporation)
Thursday, October 26 2017 - 12:30pm
LH (Laboratory Corp. of America Holdings)
Wednesday, October 25 2017 - 1:00pm
TMO (Thermo Fisher Scientific, Inc.)
Wednesday, October 25 2017 - 12:30pm
NUVA (NuVasive, Inc.)
Tuesday, October 24 2017 - 8:30pm
CNC (Centene Corp.)
Tuesday, October 24 2017 - 12:30pm
DGX (Quest Diagnostics Inc.)
Thursday, October 19 2017 - 12:30pm

AlphaGraphics you may like